Latest News in the pharma Industry

Top Stories

AiCuris Receives Orphan Drug Designation for Letermovir

AiCuris Receives Orphan Drug Designation for Letermovir

6 Jan 2012

AIC246 (Letermovir) has been granted Orphan Drug Designation in the US for the prevention of HCMV viremia and disease in at risk populations.

Read more 
Boehringer Ingelheim and FORMA in R&D Alliance

Boehringer Ingelheim and FORMA in R&D Alliance

6 Jan 2012

The agreement will focus on discovering small molecule drugs against oncology-relevant protein-protein interactions.

Read more 
USP Guidelines to Facilitate Supply Chain Integrity

USP Guidelines to Facilitate Supply Chain Integrity

6 Jan 2012

The proposed guidelines cover five main areas: Good Importation Practices, Counterfeit Drugs and Medical Devices, Best Practices to Combat Counterfeit Drug and Medical Devices, Diversion and Theft, and Natural Disasters.

Read more 
AAIPharma Acquires Celsis Analytical Services

AAIPharma Acquires Celsis Analytical Services

5 Jan 2012

The combined entity offers a comprehensive portfolio of methods validation and testing services for biotechnology, pharmaceutical and consumer products manufacturers, raw materials suppliers and manufacturers of agricultural and veterinary medicine pro...

Read more 
Ironwood and Bionomics Sign Compound Agreement

Ironwood and Bionomics Sign Compound Agreement

5 Jan 2012

The companies will collaborate on initial research and Ironwood will be responsible for worldwide development and commercialization of all products incorporating BNC210 or other licensed compounds.

Read more 
Biogen Idec & Isis in Global Antisense Program

Biogen Idec & Isis in Global Antisense Program

5 Jan 2012

Biogen Idec has the option to license ISIS-SMNRx until completion of the first successful Phase II/III trial.

Read more 
BioInvent & Servier Form Antibody Collaboration

BioInvent & Servier Form Antibody Collaboration

5 Jan 2012

Servier will have access to BioInvent's in-house pre-clinical capacities in selecting an antibody candidate for development.

Read more 
Isotechnika Signs License Agreement with Vifor

Isotechnika Signs License Agreement with Vifor

4 Jan 2012

Isotechnika has inked a deal with Swiss-based drug maker Vifor to commercialize the company’s lead drug candidate voclosporin for treatment of lupus.

Read more 
Teva Announces New CEO

Teva Announces New CEO

4 Jan 2012

Teva has named Dr. Jeremy Levin, a former senior executive at Bristol-Myers Squibb, to succeed Shlomo Yanai as new CEO in May.

Read more 
Regeneron Ends Patent Litigation with Genentech

Regeneron Ends Patent Litigation with Genentech

4 Jan 2012

Under the terms of the Agreement, Regeneron will make payments to Genentech based on U.S. sales of EYLEA through May 7, 2016.

Read more 
Alexion Pharmaceuticals to Acquire Enobia Pharma

Alexion Pharmaceuticals to Acquire Enobia Pharma

30 Dec 2011

Alexion Pharmaceuticals plans to buy drug developer Enobia Pharma in a deal that could be worth $1.08 billion.

Read more 
OPKO Completes Acquisition of FineTech Pharmaceutical

OPKO Completes Acquisition of FineTech Pharmaceutical

30 Dec 2011

OPKO Health has completed the acquisition of Israel-based FineTech which produces high potency active pharmaceutical ingredients.

Read more